EUCTR2017-002588-17-DE进行中（未招募）1 期
Safety and effects on visual function of 0.01% Atropin eye drops for myopia inhibition in children and adolescents
niversitätsklinikum Tübingen0 个研究点目标入组 30 人开始时间: 2019年6月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Children and adolescents for whom the decision was already made for treatment with 0.01% atropine based on their individual situation (eye length, observed myopia progression) and after thorough information discussion about the special status of the myopia. Determining indications for treatment and general consultation will be based on the recommendations of the scientific medical societies.
- •Age 6-17 years
- •Myopia progression of at least 0.5 dpt in the last 12 months in at least on eye
- •Myopia below 4.0 dpt
- •Written consent of at least one legal guardian and assent of the subject
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 30
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Anisometropia > 1.0 dpt.
- •Astigmatism > 1.5 Dpt.
- •Best corrected vision < 0.8
- •Eye diseases other than myopia, in particular changes of the conjunctiva, scarring of the cornea and diseases of the anterior segment of the eye
- •Known intolerance of atropine eye drops
- •Participation in another clinical trial within the last 30 days
研究者
相似试验
已完成
2 期
Safety and effects on visual function of 0.01% atropine eye drops for myopia Inhibition in children and adolescentsH52.5Disorders of accommodationDRKS00020585niversitätsklinikum TübingenTübingen28
进行中（未招募）
不适用
Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - NDSubfoveal Choroidal Neovascularization due to Age Related Macular Degeneration who did not respond to currently available treatmentsMedDRA version: 6.1Level: PTClassification code 10060823EUCTR2006-002424-42-ITOSPEDALE SACRO CUORE-DON CALABRIA150
进行中（未招募）
不适用
Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy - NDMedDRA version: 8.1Level: LLTClassification code 10012689Term: Diabetic retinopathyDiabetic RetinopathyEUCTR2006-005315-10-ITOSPEDALE SACRO CUORE-DON CALABRIA
尚未招募
不适用
Clinical trial for visual function and safety evaluation:Artificial posterior capsule construction surgery and Intraocular lens implantation with 10-0 Polypropylene surgical suture which have been used for Scleral suture fixation of intraocular lensesaphakiaJPRN-UMIN000015145Yamaguchi university hospitalophthalmology20
已完成
不适用
Evaluation of the effect on visual function in patients treated with nasolacrimal intubation using dacryoendoscopyJPRN-UMIN000021754niversity of Tsukuba100